PreDxion Bio is a precision medicine diagnostics company with a beachhead product called MicroKine, a patent-pending near-bedside diagnostic device that measures certain proteins (“cytokines”) in the blood of critically ill patients. The device helps provide physicians with critical information to accurately tailor treatments to patients’ immune response. The technology helped to save a 9-year-old cancer patient in 2015 after her treatment triggered an overactive immune response. MicroKine was able to accurately measure her immune response, which helped inform her physicians’ medical decisions.
PreDxion Bio’s recent accomplishments include:
- Won the Michigan Business Challenge in 2016, receiving the Pryor-Hale award for best business for $25,000,and the Williamson Award for $5,000 for the most outstanding business and engineering team
- Named Rice Business Challenge finalist winning $100,000 in funding
- Selected as finalists in the Accelerate Michigan Innovation Competition, which placed them at the Menlo Startup Garage in Ann Arbor
“Prior to joining the Michigan Business Challenge, PreDxion did not have a framework or mechanism for pressure-testing our assumptions for market entry. The competition, combined with amazing support from the Zell Lurie Institute, provided the structure and resources we needed to launch our venture and hopefully receive the financing necessary to bring our product to market.”– Walker McHugh, College of Literature, Science, and the Arts, BS 2011, College of Engineering, MSE 2017, Co-Founder